echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > First reported: Sjogren's syndrome coexists with such conditions, and this test is key to diagnosis

    First reported: Sjogren's syndrome coexists with such conditions, and this test is key to diagnosis

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *For medical professionals only


    First case report of pediatric Sjogren syndrome with aortic arteritis


    Sjögren's Syndrome (SS) is a diffuse connective tissue disease


    ■ The first stage: diagnosis of SS


    ▎ Case information A 9-year-old girl was diagnosed with cervical lymphadenitis due to "fever and cervical lymphadenopathy", and although the symptoms were relieved after treatment with antibacterial drugs, blood tests showed that the inflammatory markers continued to rise, and was referred to our hospital for further examination and treatment






    ■ Phase II: TAK was discovered after a five-year follow-up


    • Persistently elevated inflammatory markers, occasionally found "macaroni signs"


    Table 1 2016 ACR/EULAR primary SS classification criteria


    *Inclusion criteria and exclusion criteria, and the sum of the following 5 scores≥ 4 points



    Serological testing of autoantibodies such as ANA, RF, anti-SSA/Ro antibodies, or anti-SSB/La antibodies is a major factor



    [2]omiita M,Saito K,Kohno Y,Shimojo N,Fujikawa S,Niimi H.
    The clinical features of Sjögren's syndrome in Japanese children.
    Acta Paediatr Jpn.
    1997; 39(2):268-272.
    doi:10.
    1111/j.
    1442-200x.
    1997.
    tb03597.
    x

    [3] Misra DP,Aggarwal A,Lawrence A,Agarwal V,Misra R.
    Pediatric-onset Takayasu's arteritis:clinical features and short-term outcome.
    Rheumatol Int.
    2015; 35(10):1701-1706.
    doi:10.
    1007/s00296-015-3272-7

    Where to see more clinical cases of rheumatism?
    Come to the "Doctor's Station" and take a look 👇


    This article is from | Medical community rheumatic immunity channel

    This article is written by | Zhou Zhici

    This article is reviewed | Chen Xinpeng Deputy Chief Physician

    Responsible Editor | tangerine


    Copyright affirms the
    originality of this article, welcome to forward the circle of friends - End -
    call for papers "Medical Rheumatology and Immunology Channel" long-term recruitment of online authors, 1.
    Rheumatology and Immunology clinical practical skills, misdiagnosed cases, clinical medication, interesting content; 2.
    Interesting diagnosis and treatment stories of rheumatologists; 3.
    Heavy progress in the field of rheumatology and immunology; 4.
    Other (content that is of interest to rheumatologists can be)
    Welcome to share! We will provide you with competitive fees and a platform
    to showcase your talents.

    Submission Email: yanjin@yxj.
    org.
    cn (submissions must be replied to) The medical community strives to make its published content accurate and reliable when it is approved, but does not make any commitment and guarantee for the timeliness of the published content, as well as the accuracy and completeness of the cited information (if any), and does not assume any responsibility
    arising from the outdated content, possible inaccuracies or incompleteness of the cited information.

    Parties are requested to verify
    separately when adopting or using this as a basis for decision-making.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.